|
JP2005289809A
(ja)
*
|
2001-10-24 |
2005-10-20 |
Vlaams Interuniversitair Inst Voor Biotechnologie Vzw (Vib Vzw) |
突然変異重鎖抗体
|
|
US9321832B2
(en)
*
|
2002-06-28 |
2016-04-26 |
Domantis Limited |
Ligand
|
|
US9453251B2
(en)
|
2002-10-08 |
2016-09-27 |
Pfenex Inc. |
Expression of mammalian proteins in Pseudomonas fluorescens
|
|
EP3299393A1
(en)
|
2002-11-08 |
2018-03-28 |
Ablynx N.V. |
Single domain antibodies directed against tumour necrosis factor-alpha and uses therefor
|
|
US20060034845A1
(en)
|
2002-11-08 |
2006-02-16 |
Karen Silence |
Single domain antibodies directed against tumor necrosis factor alpha and uses therefor
|
|
US9320792B2
(en)
|
2002-11-08 |
2016-04-26 |
Ablynx N.V. |
Pulmonary administration of immunoglobulin single variable domains and constructs thereof
|
|
JP2008507294A
(ja)
|
2004-07-26 |
2008-03-13 |
ダウ グローバル テクノロジーズ インコーポレイティド |
菌株遺伝子操作による改善されたタンパク質発現のための方法
|
|
CN103254309B
(zh)
*
|
2005-05-18 |
2017-09-26 |
埃博灵克斯股份有限公司 |
针对肿瘤坏死因子α的改进的纳米体TM
|
|
DE102005023617A1
(de)
*
|
2005-05-21 |
2006-11-23 |
Aspre Ag |
Verfahren zum Mischen von Farben in einem Display
|
|
US20070269422A1
(en)
*
|
2006-05-17 |
2007-11-22 |
Ablynx N.V. |
Serum albumin binding proteins with long half-lives
|
|
AU2007293614A1
(en)
*
|
2006-09-08 |
2008-03-13 |
Ablynx N.V. |
Serum albumin binding proteins with long half-lives
|
|
ATE536369T1
(de)
|
2006-10-11 |
2011-12-15 |
Ablynx Nv |
Im wesentlichen ph-wert-unabhängigerweise an serumproteine bindende aminosäuresequenzen, verbindungen, die diese enthalten, und deren verwendung
|
|
JP2010512734A
(ja)
*
|
2006-12-13 |
2010-04-30 |
アブリンクス エン．ヴェー． |
Ｉｌ−６／ｉｌ−６受容体複合体等受容体介在性シグナル伝達に関与する複合体に特異的なポリペプチド
|
|
AU2007331672A1
(en)
*
|
2006-12-15 |
2008-06-19 |
Ablynx N.V. |
Amino acid sequences that modulate the interaction between cells of the immune system
|
|
US9512236B2
(en)
|
2006-12-19 |
2016-12-06 |
Ablynx N.V. |
Amino acid sequences directed against GPCRS and polypeptides comprising the same for the treatment of GPCR-related diseases and disorders
|
|
EP2514767A1
(en)
|
2006-12-19 |
2012-10-24 |
Ablynx N.V. |
Amino acid sequences directed against a metalloproteinase from the ADAM family and polypeptides comprising the same for the treatment of ADAM-related diseases and disorders
|
|
EP2115004A2
(en)
|
2006-12-19 |
2009-11-11 |
Ablynx N.V. |
Amino acid sequences directed against gpcrs and polypeptides comprising the same for the treatment of gpcr-related diseases and disorders
|
|
WO2008074868A1
(en)
*
|
2006-12-20 |
2008-06-26 |
Ablynx N.V. |
Oral delivery of polypeptides
|
|
JP2010518839A
(ja)
*
|
2007-02-21 |
2010-06-03 |
アブリンクス エン．ヴェー． |
血管内皮増殖因子に指向性を有するアミノ酸配列、及び過度の及び／もしくは病的な血管形成又は血管新生を特徴とする症状及び疾患を治療するためにこれを含むポリペプチド
|
|
EP2615172A1
(en)
|
2007-04-27 |
2013-07-17 |
Pfenex Inc. |
Method for rapidly screening microbial hosts to identify certain strains with improved yield and/or quality in the expression of heterologous proteins
|
|
US9580719B2
(en)
|
2007-04-27 |
2017-02-28 |
Pfenex, Inc. |
Method for rapidly screening microbial hosts to identify certain strains with improved yield and/or quality in the expression of heterologous proteins
|
|
CN101796072B
(zh)
*
|
2007-05-24 |
2014-09-24 |
埃博灵克斯股份有限公司 |
用于治疗骨疾病和病症的针对rank-l的氨基酸序列以及包括其的多肽
|
|
JP5240870B2
(ja)
|
2007-07-03 |
2013-07-17 |
アブリンクス エン．ヴェー． |
改善した免疫グロブリン配列を提供する方法
|
|
ES2667729T3
(es)
|
2007-09-26 |
2018-05-14 |
Ucb Biopharma Sprl |
Fusiones de anticuerpos con doble especificidad
|
|
CN101970490A
(zh)
|
2007-11-27 |
2011-02-09 |
埃博灵克斯股份有限公司 |
针对异二聚体细胞因子和/或其受体的氨基酸序列以及包括所述氨基酸序列的多肽
|
|
CA2717015A1
(en)
*
|
2008-03-05 |
2009-09-11 |
Ablynx Nv |
Novel antigen binding dimer-complexes, methods of making and uses thereof
|
|
GB0809069D0
(en)
|
2008-05-19 |
2008-06-25 |
Univ Leuven Kath |
Gene signatures
|
|
WO2009124931A2
(en)
|
2008-04-07 |
2009-10-15 |
Ablynx Nv |
Amino acid sequences directed against the notch pathways and uses thereof
|
|
WO2009127691A1
(en)
*
|
2008-04-17 |
2009-10-22 |
Ablynx N.V. |
Peptides capable of binding to serum proteins and compounds, constructs and polypeptides comprising the same
|
|
US8444976B2
(en)
|
2008-07-02 |
2013-05-21 |
Argen-X B.V. |
Antigen binding polypeptides
|
|
WO2010035012A1
(en)
|
2008-09-26 |
2010-04-01 |
Ucb Pharma S.A. |
Biological products
|
|
EP3011953A1
(en)
*
|
2008-10-29 |
2016-04-27 |
Ablynx N.V. |
Stabilised formulations of single domain antigen binding molecules
|
|
EP2346900A1
(en)
*
|
2008-10-29 |
2011-07-27 |
Wyeth LLC |
Methods for purification of single domain antigen binding molecules
|
|
AU2013202856B2
(en)
*
|
2008-10-29 |
2016-02-11 |
Ablynx N.V. |
Formulations of single domain antigen binding molecules
|
|
US9265834B2
(en)
*
|
2009-03-05 |
2016-02-23 |
Ablynx N.V. |
Stable formulations of polypeptides and uses thereof
|
|
US10005830B2
(en)
|
2009-03-05 |
2018-06-26 |
Ablynx N.V. |
Antigen binding dimer-complexes, methods of making/avoiding and uses thereof
|
|
EP2417163B1
(en)
|
2009-04-10 |
2019-02-27 |
Ablynx N.V. |
Improved amino acid sequences directed against il-6r and polypeptides comprising the same for the treatment of il-6r related diseases and disorders
|
|
DK2982690T3
(da)
|
2009-04-30 |
2021-04-12 |
Ablynx Nv |
Fremgangsmåde til fremstilling af domæne-antistoffer
|
|
MX340541B
(es)
|
2009-06-05 |
2016-07-13 |
Alblynx Nv |
Secuencias de aminoacidos mejoradas dirigidas contra virus sincitial respiratorio humano y polipeptidos que comprenden las mismas para la prevencion y/o tratamiento de infecciones del tracto respiratorio.
|
|
HUE051430T2
(hu)
|
2009-07-10 |
2021-03-01 |
Ablynx Nv |
Eljárás variábilis domének elõállítására
|
|
PT2473528E
(pt)
|
2009-09-03 |
2015-03-04 |
Ablynx NV |
Formulações estáveis de polipéptidos e seus usos
|
|
GB201005063D0
(en)
|
2010-03-25 |
2010-05-12 |
Ucb Pharma Sa |
Biological products
|
|
UY32917A
(es)
|
2009-10-02 |
2011-04-29 |
Boehringer Ingelheim Int |
Moléculas de unión a dll-4
|
|
US20110172398A1
(en)
|
2009-10-02 |
2011-07-14 |
Boehringer Ingelheim International Gmbh |
Bispecific binding molecules for anti-angiogenesis therapy
|
|
US9644022B2
(en)
|
2009-11-30 |
2017-05-09 |
Ablynx N.V. |
Amino acid sequences directed against human respiratory syncytial virus (HRSV) and polypeptides comprising the same for the prevention and/or treatment of respiratory tract infections
|
|
US8962807B2
(en)
|
2009-12-14 |
2015-02-24 |
Ablynx N.V. |
Single variable domain antibodies against OX40L, constructs and therapeutic use
|
|
WO2011083140A1
(en)
|
2010-01-08 |
2011-07-14 |
Ablynx Nv |
Immunoglobulin single variable domain directed against human cxcr4
|
|
WO2011095545A1
(en)
|
2010-02-05 |
2011-08-11 |
Ablynx Nv |
Peptides capable of binding to serum albumin and compounds, constructs and polypeptides comprising the same
|
|
US9120855B2
(en)
|
2010-02-10 |
2015-09-01 |
Novartis Ag |
Biologic compounds directed against death receptor 5
|
|
HRP20191071T1
(hr)
|
2010-02-11 |
2019-09-20 |
Ablynx N.V. |
Postupci i pripravci za pripremu aerosola
|
|
EP2533814A2
(en)
|
2010-02-11 |
2012-12-19 |
Ablynx N.V. |
Delivery of immunoglobulin variable domains and constructs thereof
|
|
WO2011107507A1
(en)
|
2010-03-03 |
2011-09-09 |
Boehringer Ingelheim International Gmbh |
Biparatopic abeta binding polypeptides
|
|
WO2011117423A1
(en)
|
2010-03-26 |
2011-09-29 |
Ablynx N.V. |
Immunoglobulin single variable domains directed against cxcr7
|
|
US9556273B2
(en)
|
2010-03-29 |
2017-01-31 |
Vib Vzw |
Anti-macrophage mannose receptor single variable domains for targeting and in vivo imaging of tumor-associated macrophages
|
|
US9101674B2
(en)
|
2010-03-29 |
2015-08-11 |
Vib Vzw |
Targeting and in vivo imaging of tumor-associated macrophages
|
|
SG185354A1
(en)
|
2010-05-20 |
2012-12-28 |
Ablynx Nv |
Biological materials related to her3
|
|
WO2011161263A1
(en)
|
2010-06-25 |
2011-12-29 |
Ablynx Nv |
Pharmaceutical compositions for cutaneous administration
|
|
AU2011277983C1
(en)
*
|
2010-07-16 |
2016-09-29 |
Ablynx Nv |
Modified single domain antigen binding molecules and uses thereof
|
|
US20120225081A1
(en)
|
2010-09-03 |
2012-09-06 |
Boehringer Ingelheim International Gmbh |
Vegf-binding molecules
|
|
US11644471B2
(en)
|
2010-09-30 |
2023-05-09 |
Ablynx N.V. |
Techniques for predicting, detecting and reducing aspecific protein interference in assays involving immunoglobulin single variable domains
|
|
WO2012042026A1
(en)
|
2010-09-30 |
2012-04-05 |
Ablynx Nv |
Biological materials related to c-met
|
|
EP3279214B1
(en)
|
2010-10-29 |
2024-10-09 |
Ablynx NV |
Method for the production of immunoglobulin single variable domains
|
|
KR101650995B1
(ko)
|
2010-11-08 |
2016-08-25 |
노파르티스 아게 |
Ｃｘｃｒ２ 결합 폴리펩티드
|
|
US9221892B2
(en)
|
2010-11-26 |
2015-12-29 |
Molecular Partners Ag |
Capping modules for designed ankyrin repeat proteins
|
|
EP2691415B1
(en)
|
2011-03-28 |
2018-07-11 |
Ablynx N.V. |
Method for producing solid formulations comprising immunoglobulin single variable domains
|
|
US20150158948A9
(en)
|
2011-03-28 |
2015-06-11 |
Francis Descamps |
Bispecific anti-cxcr7 immunoglobulin single variable domains
|
|
WO2012131053A1
(en)
|
2011-03-30 |
2012-10-04 |
Ablynx Nv |
Methods of treating immune disorders with single domain antibodies against tnf-alpha
|
|
US9527925B2
(en)
*
|
2011-04-01 |
2016-12-27 |
Boehringer Ingelheim International Gmbh |
Bispecific binding molecules binding to VEGF and ANG2
|
|
US20130078247A1
(en)
*
|
2011-04-01 |
2013-03-28 |
Boehringer Ingelheim International Gmbh |
Bispecific binding molecules binding to dii4 and ang2
|
|
UA117218C2
(uk)
|
2011-05-05 |
2018-07-10 |
Мерк Патент Гмбх |
Поліпептид, спрямований проти il-17a, il-17f та/або il17-a/f
|
|
EP3590950A1
(en)
|
2011-05-09 |
2020-01-08 |
Ablynx NV |
Method for the production of immunoglobulin single varible domains
|
|
RU2661677C2
(ru)
|
2011-05-27 |
2018-07-18 |
Аблинкс Нв |
Ингибирование резорбции кости с помощью связывающих rank-l пептидов
|
|
JP2014525736A
(ja)
|
2011-06-23 |
2014-10-02 |
アブリンクス エン．ヴェー． |
ＩｇＥに対する免疫グロブリン単一可変ドメイン
|
|
EP3363813A1
(en)
|
2011-06-23 |
2018-08-22 |
Ablynx NV |
Techniques for predicting, detecting and reducing aspecific protein interference in assays involving immunoglobin single variable domains
|
|
EP4350345A3
(en)
|
2011-06-23 |
2024-07-24 |
Ablynx N.V. |
Techniques for predicting, detecting and reducing aspecific protein interference in assays involving immunoglobin single variable domains
|
|
EP2723771B1
(en)
*
|
2011-06-23 |
2019-09-11 |
Ablynx NV |
Serum albumin binding proteins
|
|
NZ780183A
(en)
*
|
2011-06-23 |
2024-12-20 |
Ablynx Nv |
Techniques for predicting, detecting and reducing aspecific protein interference in assays involving immunoglobulin single variable domains
|
|
WO2013041722A1
(en)
|
2011-09-23 |
2013-03-28 |
Ablynx Nv |
Prolonged inhibition of interleukin-6 mediated signaling
|
|
CA2849409A1
(en)
|
2011-09-23 |
2013-03-28 |
Technophage, Investigacao E Desenvolvimento Em Biotecnologia, Sa |
Anti-tumor necrosis factor-alpha agents and uses thereof
|
|
US9346884B2
(en)
|
2011-09-30 |
2016-05-24 |
Ablynx N.V. |
Biological materials related to c-Met
|
|
EP2747783B1
(en)
|
2011-09-30 |
2017-06-14 |
Ablynx N.V. |
Biological materials related to c-met
|
|
UA115781C2
(uk)
|
2012-02-27 |
2017-12-26 |
Бьорінгер Інгельхайм Інтернаціональ Гмбх |
Cx3cr1-зв'язуючий поліпептид
|
|
CA2865464C
(en)
|
2012-03-30 |
2022-07-12 |
Boehringer Ingelheim International Gmbh |
Ang2-binding molecules
|
|
WO2013167883A1
(en)
|
2012-05-07 |
2013-11-14 |
The University Court Of The University Of Aberdeen |
Single domain binding molecule
|
|
US9328174B2
(en)
|
2012-05-09 |
2016-05-03 |
Novartis Ag |
Chemokine receptor binding polypeptides
|
|
CN108524919A
(zh)
|
2012-05-17 |
2018-09-14 |
延伸生物科学股份有限公司 |
用于改进的药物递送的载体
|
|
CA2874309C
(en)
|
2012-05-24 |
2021-06-15 |
Vib Vzw |
Anti-macrophage mannose receptor single variable domains for targeting and in vivo imaging of tumor-associated macrophages
|
|
RU2530553C2
(ru)
*
|
2012-11-07 |
2014-10-10 |
Федеральное государственное бюджетное образовательное учреждение высшего профессионального образования "Московский государственный университет имени М.В. Ломоносова" (МГУ) |
Рекомбинантное однодоменное антитело, способное специфически связывать фактор некроза опухолей человека, и его производные
|
|
US9315280B2
(en)
*
|
2012-11-20 |
2016-04-19 |
Lockheed Martin Corporation |
Heat pipe with axial wick
|
|
WO2014087010A1
(en)
|
2012-12-07 |
2014-06-12 |
Ablynx N.V. |
IMPROVED POLYPEPTIDES DIRECTED AGAINST IgE
|
|
US20160185847A1
(en)
|
2012-12-17 |
2016-06-30 |
Laboratoire Francais Du Fractionnement Et Des Biotechnologies |
Use of monoclonal antibodies for the treatment of inflammation and bacterial infections
|
|
WO2014111550A1
(en)
|
2013-01-17 |
2014-07-24 |
Glaxosmithkline Intellectual Property Development Limited |
Modified anti-serum albumin binding proteins
|
|
CN105102478A
(zh)
|
2013-01-30 |
2015-11-25 |
弗拉芒区生物技术研究所 |
用于筛选和药物发现目的的新型嵌合多肽
|
|
EP3590578A1
(en)
|
2013-02-05 |
2020-01-08 |
VIB vzw |
Muscarinic acetylcholine receptor binding agents and uses thereof
|
|
AR094781A1
(es)
|
2013-02-13 |
2015-08-26 |
Laboratoire Français Du Fractionnement Et Des Biotechnologies |
Anticuerpos anti-her2 (receptor 2 del factor de crecimiento epidérmico humano) altamente galactosilados y sus usos
|
|
MX2015010429A
(es)
|
2013-02-13 |
2016-05-16 |
Lab Francais Du Fractionnement |
Cetuximab con glicosilación modificada y sus usos.
|
|
BR112015019341A2
(pt)
|
2013-02-13 |
2017-08-22 |
Lab Francais Du Fractionnement |
Anticorpo anti-tnf-alfa, composição que compreende o anticorpo, método para produzir uma população de anticorpos, células epiteliais da glândula mamária, mamífero não humano transgênico, e, composição de anticorpo anti-tnf monoclonal
|
|
USRE48805E1
(en)
|
2013-03-06 |
2021-11-02 |
Vision Global Holdings Ltd. |
Method for cancer targeting treatment and detection of arginine using albumin-binding arginine deiminase fusion protein
|
|
US9255262B2
(en)
|
2013-03-06 |
2016-02-09 |
Vision Global Holdings Ltd. |
Albumin-binding arginine deminase and the use thereof
|
|
ES2872403T3
(es)
|
2013-03-14 |
2021-11-02 |
Childrens Medical Center |
Péptido Psap para el tratamiento de cánceres que expresan CD36
|
|
CA2906259C
(en)
|
2013-03-15 |
2022-12-06 |
Vib Vzw |
Anti-mmr single variable domains for prognosis and monitoring of cardiovascular diseases
|
|
KR102320189B1
(ko)
|
2013-04-23 |
2021-11-03 |
엘라스모겐 리미티드 |
특이적 결합 분자의 합성 라이브러리
|
|
NL1040254C2
(en)
|
2013-05-17 |
2014-11-24 |
Ablynx Nv |
Stable formulations of immunoglobulin single variable domains and uses thereof.
|
|
PT3060908T
(pt)
|
2013-10-21 |
2021-05-27 |
Dyax Corp |
Diagnóstico e tratamento de doenças autoimunes
|
|
WO2015121092A1
(en)
|
2014-01-30 |
2015-08-20 |
Vib Vzw |
Opioid receptor binding agents and uses thereof
|
|
RU2706551C2
(ru)
*
|
2014-03-26 |
2019-11-19 |
Селл Медика Свитзерлэнд Аг |
Связывающие элементы к фно-альфа
|
|
WO2015164747A1
(en)
|
2014-04-24 |
2015-10-29 |
Immusant, Inc. |
Methods for diagnosing celiac disease using circulating cytokines/chemokines
|
|
EP3143164B1
(en)
|
2014-05-16 |
2021-08-11 |
Children's Hospital Medical Center |
Methods for assessing responsiveness to asthma treatment based on vnn-1 expression and promoter methylation
|
|
EP3143403B1
(en)
*
|
2014-05-16 |
2021-10-27 |
Ablynx N.V. |
Methods for detecting and/or measuring anti-drug antibodies, in particular treatment-emergent anti-drug antibodies
|
|
PT3248986T
(pt)
|
2014-05-16 |
2022-04-05 |
Ablynx Nv |
Domínios variáveis de imunoglobulina
|
|
KR20250099289A
(ko)
|
2014-05-16 |
2025-07-01 |
아블린쓰 엔.브이. |
개선된 면역글로불린 가변 도메인
|
|
NL2013661B1
(en)
|
2014-10-21 |
2016-10-05 |
Ablynx Nv |
KV1.3 Binding immunoglobulins.
|
|
CA2955554C
(en)
|
2014-07-22 |
2022-07-05 |
Vib Vzw |
Methods to select for agents that stabilize protein complexes
|
|
AU2015328370B2
(en)
|
2014-10-07 |
2021-08-05 |
Immunomedics, Inc. |
Neoadjuvant use of antibody-drug conjugates
|
|
EP3207048A4
(en)
|
2014-10-17 |
2018-05-30 |
The Broad Institute, Inc. |
Compositions and methods of treating muscular dystrophy
|
|
WO2016065042A1
(en)
|
2014-10-22 |
2016-04-28 |
Extend Biosciences, Inc. |
Therapeutic vitamin d conjugates
|
|
WO2016065052A1
(en)
|
2014-10-22 |
2016-04-28 |
Extend Biosciences, Inc. |
Insulin vitamin d conjugates
|
|
US9789197B2
(en)
|
2014-10-22 |
2017-10-17 |
Extend Biosciences, Inc. |
RNAi vitamin D conjugates
|
|
MX379450B
(es)
|
2014-10-23 |
2025-03-11 |
Singh Biotechnology Llc |
Anticuerpos de un solo dominio dirigidos contra antígenos intracelulares
|
|
US20170267784A1
(en)
|
2014-10-23 |
2017-09-21 |
Singh Molecular Medicine, Llc |
Single domain antibodies directed against intracellular antigens
|
|
EP3230457B1
(en)
|
2014-12-09 |
2021-06-30 |
New York University |
Clostridial neurotoxin fusion proteins, propeptide fusions, their expression, and use
|
|
JP6862343B2
(ja)
|
2014-12-19 |
2021-04-21 |
アブリンクス エン．ヴェー． |
システイン結合ナノボディダイマー
|
|
HRP20191824T1
(hr)
|
2015-01-08 |
2020-01-24 |
BioNTech SE |
Agonistička sredstva za vezivanje tnf receptora
|
|
JP6895421B2
(ja)
*
|
2015-03-31 |
2021-06-30 |
ブイエイチスクエアード リミテッド |
ポリペプチド
|
|
HK1250040A1
(zh)
|
2015-03-31 |
2018-11-23 |
Sorriso Pharmaceuticals, Inc. |
多肽
|
|
CA2981098A1
(en)
|
2015-03-31 |
2016-10-06 |
Vhsquared Limited |
Peptide construct having a protease-cleavable linker
|
|
RU2769470C2
(ru)
|
2015-04-02 |
2022-04-01 |
Молекьюлар Партнерс Аг |
Рекомбинантные связывающие белки и их применение
|
|
CA2981543A1
(en)
|
2015-04-22 |
2016-10-27 |
Immunomedics, Inc. |
Isolation, detection, diagnosis and/or characterization of circulating trop-2-positive cancer cells
|
|
SI3294319T1
(sl)
|
2015-05-13 |
2024-09-30 |
Ablynx Nv |
Polipeptidi, ki rekrutirajo celice T na osnovi reaktivnosti CD3
|
|
EP3611192B1
(en)
|
2015-05-13 |
2025-03-05 |
Ablynx N.V. |
T cell recruiting polypeptides based on tcr alpha/beta reactivity
|
|
CN111234027A
(zh)
|
2015-05-21 |
2020-06-05 |
哈普恩治疗公司 |
三特异性结合蛋白质及使用方法
|
|
GB201510758D0
(en)
|
2015-06-18 |
2015-08-05 |
Ucb Biopharma Sprl |
Novel TNFa structure for use in therapy
|
|
US10973912B2
(en)
|
2015-06-29 |
2021-04-13 |
President And Fellows Of Harvard College |
Treatment for myopathy
|
|
PL3316885T3
(pl)
|
2015-07-01 |
2021-12-06 |
Immunomedics, Inc. |
Immunokoniugaty przeciwciało-sn-38 z linkerem cl2a
|
|
WO2017048872A1
(en)
|
2015-09-14 |
2017-03-23 |
Leukemia Therapeutics, LLC |
Identification of novel diagnostics and therapeutics by modulating rhoh
|
|
TWI746473B
(zh)
|
2015-11-02 |
2021-11-21 |
美商辛分子醫藥有限公司 |
針對細胞內抗原之單域抗體
|
|
NO2768984T3
(enExample)
*
|
2015-11-12 |
2018-06-09 |
|
|
|
US10925969B2
(en)
|
2015-11-13 |
2021-02-23 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Service |
Anti-BCMA polypeptides and proteins
|
|
EP3974449A1
(en)
|
2015-11-13 |
2022-03-30 |
Ablynx NV |
Improved serum albumin-binding immunoglobulin variable domains
|
|
CN109071639B
(zh)
|
2015-11-18 |
2022-07-08 |
默沙东公司 |
Pd1/ctla4结合剂
|
|
SG10201911035QA
(en)
|
2015-11-18 |
2020-01-30 |
Merck Sharp & Dohme |
Pd1 and/or lag3 binders
|
|
CN120535622A
(zh)
*
|
2015-11-18 |
2025-08-26 |
埃博灵克斯股份有限公司 |
改进的血清白蛋白结合剂
|
|
HK1254952A1
(zh)
|
2015-11-18 |
2019-08-02 |
Merck Sharp & Dohme Llc |
Ctla4结合剂
|
|
CA3006398A1
(en)
*
|
2015-11-27 |
2017-06-01 |
Ablynx Nv |
Polypeptides inhibiting cd40l
|
|
MA54648A
(fr)
|
2015-12-04 |
2021-11-10 |
Boehringer Ingelheim Int |
Polypeptides biparatopiques antagonistes de la signalisation wnt dans des cellules tumorales
|
|
GB201522394D0
(en)
*
|
2015-12-18 |
2016-02-03 |
Ucb Biopharma Sprl |
Antibodies
|
|
US10465003B2
(en)
*
|
2016-02-05 |
2019-11-05 |
Janssen Biotech, Inc. |
Anti-TNF antibodies, compositions, methods and use for the treatment or prevention of type 1 diabetes
|
|
CN116769054A
(zh)
|
2016-02-05 |
2023-09-19 |
奥里尼斯生物科学私人有限公司 |
双特异性信号传导剂及其用途
|
|
US11248057B2
(en)
|
2016-03-07 |
2022-02-15 |
Vib Vzw |
CD20 binding single domain antibodies
|
|
WO2017191108A1
(en)
|
2016-05-02 |
2017-11-09 |
Ablynx Nv |
Treatment of rsv infection
|
|
CN109563141A
(zh)
|
2016-05-13 |
2019-04-02 |
奥里尼斯生物科学公司 |
对非细胞结构的治疗性靶向
|
|
CN109641046B
(zh)
|
2016-05-20 |
2023-11-07 |
哈普恩治疗公司 |
单链可变片段cd3结合蛋白质
|
|
BR112018073739A2
(pt)
*
|
2016-05-20 |
2019-02-26 |
Harpoon Therapeutics, Inc. |
proteína de ligação de albumina sérica de domínio único
|
|
US11623958B2
(en)
|
2016-05-20 |
2023-04-11 |
Harpoon Therapeutics, Inc. |
Single chain variable fragment CD3 binding proteins
|
|
CA3029133C
(en)
|
2016-06-23 |
2024-04-30 |
Ablynx N.V. |
Improved pharmacokinetic assays for immunoglobulin single variable domains
|
|
WO2018007442A1
(en)
|
2016-07-06 |
2018-01-11 |
Ablynx N.V. |
Treatment of il-6r related diseases
|
|
WO2018029182A1
(en)
|
2016-08-08 |
2018-02-15 |
Ablynx N.V. |
Il-6r single variable domain antibodies for treatment of il-6r related diseases
|
|
EP3512880A1
(en)
|
2016-09-15 |
2019-07-24 |
Ablynx NV |
Immunoglobulin single variable domains directed against macrophage migration inhibitory factor
|
|
EP3519438A1
(en)
|
2016-09-30 |
2019-08-07 |
VHsquared Limited |
Compositions
|
|
AU2017361846B2
(en)
|
2016-11-16 |
2024-08-22 |
Ablynx Nv |
T cell recruiting polypeptides capable of binding CD123 and TCR alpha/beta
|
|
JP6812551B2
(ja)
|
2016-11-23 |
2021-01-13 |
ハープーン セラピューティクス，インク． |
前立腺特異的膜抗原結合タンパク質
|
|
JP7215997B2
(ja)
|
2016-11-23 |
2023-01-31 |
ハープーン セラピューティクス，インク． |
前立腺特異的膜抗原（ｐｓｍａ）を標的とする三重特異性タンパク質と使用方法
|
|
WO2018099968A1
(en)
|
2016-11-29 |
2018-06-07 |
Ablynx N.V. |
Treatment of infection by respiratory syncytial virus (rsv)
|
|
CN117164710A
(zh)
|
2016-12-07 |
2023-12-05 |
埃博灵克斯股份有限公司 |
改进的血清白蛋白结合免疫球蛋白单可变结构域
|
|
GB201621907D0
(en)
|
2016-12-21 |
2017-02-01 |
Ucb Biopharma Sprl And Sanofi |
Antibody epitope
|
|
CN107674122A
(zh)
*
|
2016-12-28 |
2018-02-09 |
天津天锐生物科技有限公司 |
一种识别人血清白蛋白的单域抗体
|
|
ES2991459T3
(es)
|
2017-01-17 |
2024-12-03 |
Ablynx Nv |
Ligantes de albúmina sérica mejorados
|
|
SG10202108973SA
(en)
|
2017-01-17 |
2021-09-29 |
Ablynx Nv |
Improved serum albumin binders
|
|
EP3577133A1
(en)
|
2017-02-06 |
2019-12-11 |
Orionis Biosciences NV |
Targeted chimeric proteins and uses thereof
|
|
AU2018220516B2
(en)
|
2017-02-16 |
2025-03-06 |
Sonnet BioTherapeutics, Inc. |
Albumin binding domain fusion proteins
|
|
US11535668B2
(en)
|
2017-02-28 |
2022-12-27 |
Harpoon Therapeutics, Inc. |
Inducible monovalent antigen binding protein
|
|
US11964002B2
(en)
|
2017-02-28 |
2024-04-23 |
Vib Vzw |
Means and methods for oral protein delivery
|
|
AU2018241286B2
(en)
|
2017-03-31 |
2025-03-13 |
Ablynx N.V. |
Improved immunogenicity assays
|
|
WO2018206734A1
(en)
|
2017-05-11 |
2018-11-15 |
Vib Vzw |
Glycosylation of variable immunoglobulin domains
|
|
CA3063362A1
(en)
|
2017-05-12 |
2018-11-15 |
Harpoon Therapeutics, Inc. |
Msln targeting trispecific proteins and methods of use
|
|
CA3063359A1
(en)
|
2017-05-12 |
2018-11-15 |
Harpoon Therapeutics, Inc. |
Mesothelin binding proteins
|
|
US11033636B2
(en)
|
2017-05-31 |
2021-06-15 |
Boehringer Ingelheim International Gmbh |
Polypeptides antagonizing Wnt signaling in tumor cells
|
|
LT3630847T
(lt)
|
2017-06-02 |
2024-12-10 |
Merck Patent Gmbh |
Adamts surišantys imunoglobulinai
|
|
IL270951B2
(en)
|
2017-06-02 |
2025-05-01 |
Merck Patent Gmbh |
ADAMTS5, MMP13 and aggrecan-binding polypeptides
|
|
EP3630822A1
(en)
|
2017-06-02 |
2020-04-08 |
Boehringer Ingelheim International GmbH |
Anti-cancer combination therapy
|
|
CN110997716B
(zh)
|
2017-06-02 |
2024-03-15 |
埃博灵克斯股份有限公司 |
结合聚集蛋白聚糖的免疫球蛋白
|
|
KR102778120B1
(ko)
|
2017-06-02 |
2025-03-06 |
메르크 파텐트 게엠베하 |
Mmp13 결합성 면역글로불린
|
|
GB201710973D0
(en)
|
2017-07-07 |
2017-08-23 |
Avacta Life Sciences Ltd |
Scaffold proteins
|
|
CA3070253A1
(en)
|
2017-07-19 |
2019-01-24 |
Vib Vzw |
Serum albumin binding agents
|
|
IL315737A
(en)
|
2017-10-13 |
2024-11-01 |
Harpoon Therapeutics Inc |
B-cell maturation antigen-binding proteins
|
|
UA129446C2
(uk)
|
2017-10-13 |
2025-04-30 |
Гарпун Терап'Ютікс, Інк. |
Триспецифічні білки і способи їх застосування
|
|
WO2019086548A1
(en)
|
2017-10-31 |
2019-05-09 |
Vib Vzw |
Novel antigen-binding chimeric proteins and methods and uses thereof
|
|
WO2019133827A1
(en)
*
|
2017-12-29 |
2019-07-04 |
Board Of Regents, The University Of Texas System |
Antimicrobial nanobodies
|
|
WO2019148089A1
(en)
|
2018-01-26 |
2019-08-01 |
Orionis Biosciences Inc. |
Xcr1 binding agents and uses thereof
|
|
MX2020008208A
(es)
|
2018-02-05 |
2020-11-09 |
Orionis Biosciences Inc |
Agentes de unión a fibroblastos y uso de estos.
|
|
WO2019155041A1
(en)
|
2018-02-12 |
2019-08-15 |
Vib Vzw |
Gβγ COMPLEX ANTIBODIES AND USES THEREOF
|
|
WO2019165105A1
(en)
*
|
2018-02-26 |
2019-08-29 |
The Board Of Trustees Of The Leland Stanford Junior University |
Ligands of the urokinase receptor and their use in treating, detecting, and imaging cancer
|
|
EP3758742A1
(en)
|
2018-03-01 |
2021-01-06 |
Vrije Universiteit Brussel |
Human pd-l1-binding immunoglobulins
|
|
US12123881B2
(en)
|
2018-04-20 |
2024-10-22 |
Unm Rainforest Innovations |
Rap1-Gtp, Rac1-GTP and FMS-like tyrosine kinase 3 ligand (FLT3-L) as biomarkers for early detection of sepsis
|
|
WO2019222283A1
(en)
|
2018-05-14 |
2019-11-21 |
Harpoon Therapeutics, Inc. |
Binding moiety for conditional activation of immunoglobulin molecules
|
|
CN110613838A
(zh)
*
|
2018-06-19 |
2019-12-27 |
姜石松 |
增强细胞通透性的多肽及其应用
|
|
DE102018122275A1
(de)
|
2018-09-12 |
2020-03-12 |
Osram Opto Semiconductors Gmbh |
Lichtemittierendes bauteil und verfahren zum betreiben eines lichtemittierenden bauteils
|
|
US12195544B2
(en)
|
2018-09-21 |
2025-01-14 |
Harpoon Therapeutics, Inc. |
EGFR binding proteins and methods of use
|
|
EP3856771A4
(en)
|
2018-09-25 |
2022-06-29 |
Harpoon Therapeutics, Inc. |
Dll3 binding proteins and methods of use
|
|
EP3636657A1
(en)
|
2018-10-08 |
2020-04-15 |
Ablynx N.V. |
Chromatography-free antibody purification method
|
|
CN111138536B
(zh)
*
|
2018-11-06 |
2021-07-09 |
瑞阳(苏州)生物科技有限公司 |
抗人血清白蛋白单域抗体的制备及其应用
|
|
CN111138537B
(zh)
*
|
2018-11-06 |
2021-07-09 |
瑞阳(苏州)生物科技有限公司 |
一种抗人血清白蛋白抗体片段、制备方法和应用
|
|
US12410225B2
(en)
|
2018-11-08 |
2025-09-09 |
Orionis Biosciences, Inc |
Modulation of dendritic cell lineages
|
|
GB201818460D0
(en)
*
|
2018-11-13 |
2018-12-26 |
Crescendo Biologics Ltd |
Single domain antibodies that bind human serum albumin
|
|
CN111423509B
(zh)
*
|
2019-01-10 |
2021-07-09 |
瑞阳(苏州)生物科技有限公司 |
抗hsa单域抗体及其融合蛋白的亲和层析纯化方法
|
|
CN109627334B
(zh)
*
|
2019-01-29 |
2020-07-17 |
康元医疗科技(大连)有限公司 |
一种纳米抗体、以该纳米抗体为配基的吸附剂及其用途
|
|
GB201901306D0
(en)
|
2019-01-30 |
2019-03-20 |
Immunocore Ltd |
Multi-domain binding molecules
|
|
TW202104258A
(zh)
|
2019-03-29 |
2021-02-01 |
德商百靈佳殷格翰國際股份有限公司 |
抗癌組合療法
|
|
BR112021016520A2
(pt)
|
2019-03-29 |
2021-10-26 |
Boehringer Ingelheim International Gmbh |
Terapia de combinação anticâncer
|
|
SG11202111980QA
(en)
|
2019-04-29 |
2021-11-29 |
Confo Therapeutics N V |
Screening methods and assays for use with transmembrane proteins, in particular with gpcrs
|
|
EP3962599A1
(en)
|
2019-04-30 |
2022-03-09 |
Vib Vzw |
Cystic fibrosis transmembrane conductance regulator stabilizing agents
|
|
WO2020239934A1
(en)
|
2019-05-28 |
2020-12-03 |
Vib Vzw |
Cd8+ t-cells lacking plexins and their application in cancer treatment
|
|
US20220220197A1
(en)
|
2019-05-28 |
2022-07-14 |
Vib Vzw |
Cancer Treatment by Targeting Plexins in the Immune Compartment
|
|
MX2021014649A
(es)
|
2019-06-04 |
2022-01-06 |
Molecular Partners Ag |
Dominio de repetición de anquirina diseñado con estabilidad mejorada.
|
|
AU2020294980A1
(en)
|
2019-06-21 |
2022-02-17 |
Sorriso Pharmaceuticals, Inc. |
Polypeptides
|
|
EP3986931A1
(en)
|
2019-06-21 |
2022-04-27 |
Sorriso Pharmaceuticals, Inc. |
Polypeptides
|
|
MX2021015762A
(es)
|
2019-06-21 |
2022-04-18 |
Sorriso Pharmaceuticals Inc |
Composiciones.
|
|
TWI844709B
(zh)
|
2019-07-31 |
2024-06-11 |
美商美國禮來大藥廠 |
鬆弛素(relaxin)類似物及其使用方法
|
|
CN112409480B
(zh)
*
|
2019-08-20 |
2024-08-27 |
四川科伦博泰生物医药股份有限公司 |
结合血清白蛋白的蛋白及其用途
|
|
WO2021039574A1
(ja)
*
|
2019-08-23 |
2021-03-04 |
株式会社カネカ |
Ｏ結合型糖鎖修飾が抑制された重鎖抗体
|
|
CN115947846A
(zh)
|
2019-09-12 |
2023-04-11 |
普米斯生物技术(珠海)有限公司 |
一种抗pd-l1纳米抗体及其衍生物和用途
|
|
CN110642946A
(zh)
*
|
2019-09-30 |
2020-01-03 |
中国药科大学 |
一种人源化纳米抗体及其制备方法
|
|
TW202128775A
(zh)
|
2019-10-16 |
2021-08-01 |
英商阿法克塔生命科學有限公司 |
PD-L1抑制劑-TGFβ抑制劑雙特異性藥物部分
|
|
WO2021078786A1
(en)
|
2019-10-21 |
2021-04-29 |
Vib Vzw |
Nanodisc-specific antigen-binding chimeric proteins
|
|
CN112746331A
(zh)
*
|
2019-10-29 |
2021-05-04 |
安升（上海）医药科技有限公司 |
半衰期延长的药物及其文库、以及制备方法和应用
|
|
BR112022009087A2
(pt)
|
2019-11-11 |
2022-07-26 |
Ibi Ag Innovative Bio Insecticides Ltd |
Nanocorpos para controle de insetos e usos dos mesmos
|
|
WO2021105438A1
(en)
|
2019-11-27 |
2021-06-03 |
Vib Vzw |
Positive allosteric modulators of the calcium-sensing receptor
|
|
CA3163764A1
(en)
*
|
2019-12-06 |
2021-06-10 |
Ablynx Nv |
Polypeptides comprising immunoglobulin single variable domains targeting tnfa and ox40l
|
|
CN114981300B
(zh)
|
2019-12-06 |
2025-10-31 |
艾伯霖克斯公司 |
包含靶向TNFα和IL-23的免疫球蛋白单个可变结构域的多肽
|
|
AU2020400938A1
(en)
|
2019-12-09 |
2022-07-28 |
Ablynx Nv |
Polypeptides comprising immunoglobulin single variable domains targeting IL-13 and TSLP
|
|
GB201918279D0
(en)
|
2019-12-12 |
2020-01-29 |
Vib Vzw |
Glycosylated single chain immunoglobulin domains
|
|
CN110988361B
(zh)
*
|
2019-12-13 |
2020-09-18 |
山东民康生物科技有限公司 |
人血清白蛋白去除试剂盒
|
|
EP4077372A1
(en)
|
2019-12-20 |
2022-10-26 |
Vib Vzw |
Nanobody exchange chromatography
|
|
CN112300289B
(zh)
*
|
2019-12-30 |
2022-06-10 |
中国药科大学 |
RGD4C融合抗TNFα纳米抗体蛋白、制备方法及其应用
|
|
CA3163172A1
(en)
|
2020-01-08 |
2021-07-15 |
Peter Verheesen |
Methods for treating pemphigus disorders
|
|
WO2021140205A1
(en)
|
2020-01-10 |
2021-07-15 |
Confo Therapeutics N.V. |
Methods for generating antibodies and antibody fragments and libraries comprising same
|
|
WO2021156490A2
(en)
|
2020-02-06 |
2021-08-12 |
Vib Vzw |
Corona virus binders
|
|
IL295448A
(en)
|
2020-02-21 |
2022-10-01 |
Harpoon Therapeutics Inc |
flt3 binding proteins and methods of use
|
|
JP2023514654A
(ja)
|
2020-02-25 |
2023-04-06 |
ブイアイビー ブイゼットダブリュ |
ロイシンリッチリピートキナーゼ２のアロステリック調節因子
|
|
CA3170750A1
(en)
*
|
2020-03-06 |
2021-09-10 |
Yi Shi |
Serum albumin binding nanobody compositions and methods for using the same
|
|
US20230279115A1
(en)
|
2020-04-22 |
2023-09-07 |
Mabwell (shanghai) Bioscience Co., Ltd. |
Single variable domain antibody targeting human programmed death ligand 1 (pd-l1) and derivative thereof
|
|
WO2021229104A1
(en)
|
2020-05-15 |
2021-11-18 |
Université de Liège |
Anti-cd38 single-domain antibodies in disease monitoring and treatment
|
|
GB202101299D0
(en)
|
2020-06-09 |
2021-03-17 |
Avacta Life Sciences Ltd |
Diagnostic polypetides and methods
|
|
WO2022003156A1
(en)
|
2020-07-02 |
2022-01-06 |
Oncurious Nv |
Ccr8 non-blocking binders
|
|
CN116284373A
(zh)
*
|
2020-08-14 |
2023-06-23 |
上海洛启生物医药技术有限公司 |
非pH依赖性长效型抗血清白蛋白纳米抗体及其应用
|
|
CN114106190B
(zh)
*
|
2020-08-31 |
2025-04-08 |
普米斯生物技术(珠海)有限公司 |
一种抗vegf/pd-l1双特异性抗体及其用途
|
|
WO2022063947A1
(en)
|
2020-09-24 |
2022-03-31 |
Vib Vzw |
Combination of p2y6 inhibitors and immune checkpoint inhibitors
|
|
WO2022063957A1
(en)
|
2020-09-24 |
2022-03-31 |
Vib Vzw |
Biomarker for anti-tumor therapy
|
|
CA3195687A1
(en)
|
2020-09-25 |
2022-03-31 |
Ablynx Nv |
Polypeptides comprising immunoglobulin single variable domains targeting il-13 and ox40l
|
|
CN115244076B
(zh)
|
2020-10-27 |
2023-08-04 |
北京质肽生物医药科技有限公司 |
Gdf15融合蛋白及其用途
|
|
WO2022098745A1
(en)
|
2020-11-03 |
2022-05-12 |
Indi Molecular, Inc. |
Compositions, delivery systems, and methods useful in tumor therapy
|
|
WO2022098743A1
(en)
|
2020-11-03 |
2022-05-12 |
Indi Molecular, Inc. |
Compositions, imaging, and therapeutic methods targeting folate receptor 1 (folr1)
|
|
WO2022117569A1
(en)
|
2020-12-02 |
2022-06-09 |
Oncurious Nv |
A ccr8 antagonist antibody in combination with a lymphotoxin beta receptor agonist antibody in therapy against cancer
|
|
JP2024508207A
(ja)
|
2020-12-02 |
2024-02-26 |
ブイアイビー ブイゼットダブリュ |
がんに対する組み合わせ治療におけるｌｔｂｒアゴニスト
|
|
KR20230123497A
(ko)
|
2020-12-18 |
2023-08-23 |
아블린쓰 엔.브이. |
IL-6 및 TNF-α를 표적화하는 면역글로불린 단일 가변도메인을 포함하는 폴리펩티드
|
|
WO2022129637A1
(en)
|
2020-12-18 |
2022-06-23 |
Ablynx Nv |
T cell recruiting polypeptides based on tcr alpha/beta reactivity
|
|
IL303783A
(en)
|
2020-12-18 |
2023-08-01 |
Sanofi Sa |
Polypeptides comprising immunoglobulin single variable domains targeting glypican-3 and t cell receptor
|
|
GB202020502D0
(en)
|
2020-12-23 |
2021-02-03 |
Vib Vzw |
Antibody composistion for treatment of corona virus infection
|
|
WO2022136650A1
(en)
|
2020-12-24 |
2022-06-30 |
Oncurious Nv |
Murine cross-reactive human ccr8 binders
|
|
EP4267618A1
(en)
|
2020-12-24 |
2023-11-01 |
Vib Vzw |
Non-blocking human ccr8 binders
|
|
EP4267617A1
(en)
|
2020-12-24 |
2023-11-01 |
Vib Vzw |
Human ccr8 binders
|
|
CN117794566A
(zh)
|
2021-02-05 |
2024-03-29 |
Vib研究所 |
沙贝病毒结合剂
|
|
KR20230141853A
(ko)
|
2021-02-05 |
2023-10-10 |
브이아이비 브이지더블유 |
사베코바이러스 결합제
|
|
CA3211257A1
(en)
|
2021-02-17 |
2022-08-25 |
Vib Vzw |
Inhibition of slc4a4 in the treatment of cancer
|
|
EP4294516A1
(en)
|
2021-02-19 |
2023-12-27 |
Vib Vzw |
Cation-independent mannose-6-phosphate receptor binders
|
|
WO2022199804A1
(en)
|
2021-03-24 |
2022-09-29 |
Vib Vzw |
Nek6 inhibition to treat als and ftd
|
|
WO2022234003A1
(en)
|
2021-05-07 |
2022-11-10 |
Avacta Life Sciences Limited |
Cd33 binding polypeptides with stefin a protein
|
|
WO2022242892A1
(en)
|
2021-05-17 |
2022-11-24 |
Université de Liège |
Anti-cd38 single-domain antibodies in disease monitoring and treatment
|
|
WO2022268993A1
(en)
|
2021-06-23 |
2022-12-29 |
Vib Vzw |
Means and methods for selection of specific binders
|
|
US20240343811A1
(en)
|
2021-06-29 |
2024-10-17 |
Shandong Simcere Biopharmacutical Co., Ltd. |
Cd16 antibody and use thereof
|
|
EP4288461A4
(en)
|
2021-07-14 |
2025-07-02 |
Beijing Ql Biopharmaceutical Co Ltd |
FUSION POLYPEPTIDES FOR METABOLIC DISORDERS
|
|
CN113527502B
(zh)
*
|
2021-07-20 |
2023-01-17 |
福建医科大学 |
一种用于治疗类风湿性关节炎的纳米抗体重组蛋白
|
|
EP4377352A2
(en)
|
2021-07-30 |
2024-06-05 |
Vib Vzw |
Cation-independent mannose-6-phosphate receptor binders for targeted protein degradation
|
|
CA3227972A1
(en)
|
2021-07-30 |
2023-02-02 |
Shandong Simcere Biopharmaceutical Co., Ltd. |
Anti-pvrig/anti-tigit bispecific antibodies and applications thereof
|
|
EP4413038A1
(en)
|
2021-10-07 |
2024-08-14 |
Avacta Life Sciences Limited |
Pd-l1 binding affimers
|
|
TW202332694A
(zh)
|
2021-10-07 |
2023-08-16 |
英商阿凡克塔生命科學公司 |
血清半衰期延長之ｐｄ－ｌ１結合多肽
|
|
CN118696058A
(zh)
|
2021-12-03 |
2024-09-24 |
山东先声生物制药有限公司 |
抗bcma纳米抗体及其应用
|
|
CN113912730B
(zh)
*
|
2021-12-14 |
2022-03-04 |
北京科诺信诚科技有限公司 |
缓释的抗FcRn抗体或抗原结合片段及其应用
|
|
EP4448574A1
(en)
|
2021-12-17 |
2024-10-23 |
Ablynx N.V. |
Polypeptides comprising immunoglobulin single variable domains targeting tcralphabeta, cd33 and cd123
|
|
JP2025501206A
(ja)
|
2021-12-31 |
2025-01-17 |
山▲東▼先声生物制▲薬▼有限公司 |
Ｇｐｒｃ５ｄ抗体及びその応用
|
|
EP4463479A1
(en)
|
2022-01-12 |
2024-11-20 |
Vib Vzw |
Human ntcp binders for therapeutic use and liver-specific targeted delivery
|
|
WO2023148397A1
(en)
|
2022-02-07 |
2023-08-10 |
Vib Vzw |
Engineered stabilizing aglycosylated fc-regions
|
|
CN119213021A
(zh)
|
2022-02-10 |
2024-12-27 |
艾菲赛尔治疗株式会社 |
与CD40L特异性结合的Stefin A蛋白变体及其用途
|
|
CN116925215A
(zh)
*
|
2022-03-31 |
2023-10-24 |
普米斯生物技术(珠海)有限公司 |
抗血清白蛋白纳米抗体及其衍生物
|
|
EP4508082A1
(en)
|
2022-04-13 |
2025-02-19 |
Vib Vzw |
An ltbr agonist in combination therapy against cancer
|
|
WO2023218243A1
(en)
|
2022-05-12 |
2023-11-16 |
Avacta Life Sciences Limited |
Lag-3/pd-l1 binding fusion proteins
|
|
US20250313611A1
(en)
|
2022-05-18 |
2025-10-09 |
Vib Vzw |
Sarbecovirus spike s2 subunit binders
|
|
CN115028719B
(zh)
*
|
2022-05-27 |
2023-01-13 |
深圳市人民医院 |
血清白蛋白结合纳米抗体及其制备方法与应用
|
|
JP2025522351A
(ja)
|
2022-06-06 |
2025-07-15 |
山▲東▼先声生物制▲薬▼有限公司 |
Ｂｃｍａ、ｇｐｒｃ５ｄ及びｔ細胞を標的とする多重特異性抗体並びにその応用
|
|
US20240109965A1
(en)
|
2022-06-14 |
2024-04-04 |
Ablynx N.V. |
Immunoglobulin single variable domains targeting t cell receptor
|
|
CN119630697A
(zh)
|
2022-06-15 |
2025-03-14 |
阿根思有限公司 |
Ph依赖性hsa结合分子及使用方法
|
|
WO2024003873A1
(en)
*
|
2022-06-30 |
2024-01-04 |
Intrexon Actobiotics Nv D/B/A Precigen Actobio |
Single variable domain antibodies against tumor necrosis factor-alpha
|
|
JP2025523630A
(ja)
|
2022-07-04 |
2025-07-23 |
ブイアイビー ブイゼットダブリュ |
血液－脳脊髄液関門通過抗体
|
|
JP2025526384A
(ja)
|
2022-07-27 |
2025-08-13 |
アブリンクス エン．ヴェー． |
新生児型Ｆｃ受容体の特異的エピトープに結合するポリペプチド
|
|
WO2024038112A1
(en)
|
2022-08-17 |
2024-02-22 |
Institut National de la Santé et de la Recherche Médicale |
Improved anti-albumin nanobodies and their uses
|
|
WO2024068744A1
(en)
|
2022-09-27 |
2024-04-04 |
Vib Vzw |
Antivirals against human parainfluenza virus
|
|
JP2025534350A
(ja)
|
2022-09-30 |
2025-10-15 |
エクステンド バイオサイエンシズ インコーポレーテッド |
長時間作用型副甲状腺ホルモン
|
|
WO2024083843A1
(en)
|
2022-10-18 |
2024-04-25 |
Confo Therapeutics N.V. |
Amino acid sequences directed against the melanocortin 4 receptor and polypeptides comprising the same for the treatment of mc4r-related diseases and disorders
|
|
WO2024088424A1
(zh)
|
2022-10-28 |
2024-05-02 |
嘉和生物药业有限公司 |
新型抗ctla4抗体
|
|
JP2025537809A
(ja)
|
2022-11-15 |
2025-11-20 |
アイメック・ヴェーゼットウェー |
液滴操作のための方法およびシステム
|
|
EP4634214A1
(en)
|
2022-12-15 |
2025-10-22 |
Aarhus Universitet |
Synthetic activation of multimeric transmembrane receptors
|
|
TW202440614A
(zh)
|
2022-12-23 |
2024-10-16 |
比利時商艾伯霖克斯公司 |
基於蛋白質的接合載體
|
|
AU2024207151A1
(en)
|
2023-01-09 |
2025-06-19 |
Odyssey Therapeutics, Inc. |
Anti-tnfr2 antigen-binding proteins and uses thereof
|
|
CN120530125A
(zh)
*
|
2023-01-18 |
2025-08-22 |
北京质肽生物医药科技有限公司 |
融合多肽的液体药物组合物及其使用方法
|
|
AU2024208858A1
(en)
|
2023-01-20 |
2025-06-19 |
Boehringer Ingelheim International Gmbh |
Il-12 fc fusion proteins
|
|
EP4655323A1
(en)
|
2023-01-27 |
2025-12-03 |
Vrije Universiteit Brussel |
Cd8b-binding polypeptides
|
|
WO2024156888A1
(en)
|
2023-01-27 |
2024-08-02 |
Vib Vzw |
Cd163-binding conjugates
|
|
TW202448926A
(zh)
|
2023-02-17 |
2024-12-16 |
比利時商艾伯霖克斯公司 |
結合新生兒fc受體之多肽
|
|
WO2024175787A1
(en)
|
2023-02-24 |
2024-08-29 |
Vrije Universiteit Brussel |
Anti-inflammatory pannexin 1 channel inhibitors
|
|
US20240344078A1
(en)
|
2023-03-14 |
2024-10-17 |
Aarhus Universitet |
Genetically altered nfr5 receptor kinases
|
|
TW202444757A
(zh)
|
2023-03-14 |
2024-11-16 |
美商奧迪希治療公司 |
抗cd25抗原結合蛋白及其用途
|
|
WO2024200987A1
(en)
|
2023-03-31 |
2024-10-03 |
Avacta Life Sciences Limited |
Tnfr2 binding polypeptides and methods of use
|
|
FR3147278A1
(fr)
|
2023-03-31 |
2024-10-04 |
Avacta Life Sciences Limited |
Polypeptides de liaison au tnfr2 et procedes d'utilisation
|
|
AU2024243709A1
(en)
|
2023-04-03 |
2025-11-06 |
Katholieke Universiteit Leuven |
Blood-brain barrier crossing antibodies
|
|
WO2024226410A1
(en)
|
2023-04-24 |
2024-10-31 |
Merck Sharp & Dohme Llc |
Trop2 binders and conjugates thereof
|
|
WO2024231348A1
(en)
|
2023-05-11 |
2024-11-14 |
Vib Vzw |
Slc4a4/nbce1 inhibitors
|
|
TW202448951A
(zh)
|
2023-05-17 |
2024-12-16 |
美商奧迪希治療公司 |
經修飾之單域抗體
|
|
WO2024240162A1
(en)
|
2023-05-23 |
2024-11-28 |
Shanghai Allygen Biologics Co., Ltd. |
Pd-l1 and trop-2 targeting conjugates comprising effector molecules and uses thereof
|
|
WO2024261235A1
(en)
|
2023-06-22 |
2024-12-26 |
Ablynx Nv |
Chimeric proteins for modulating cytokine receptor activity
|
|
WO2024261344A1
(en)
|
2023-06-23 |
2024-12-26 |
Vib Vzw |
Novel binders targeting the multi-drug resistant pathogen acinetobacter baumannii
|
|
TW202515917A
(zh)
|
2023-06-29 |
2025-04-16 |
美商奧迪希治療公司 |
抗trailr2抗原結合蛋白及其用途
|
|
EP4483951A1
(en)
|
2023-06-30 |
2025-01-01 |
Université de Liège |
Single-domain antibody for inhibition of neutrophil elastase activity
|
|
AR133188A1
(es)
|
2023-07-05 |
2025-09-03 |
Ablynx Nv |
ANTAGONISTAS DE FcRn MEJORADOS PARA EL TRATAMIENTO DE ENFERMEDADES Y TRASTORNOS RELACIONADOS CON IgG
|
|
US20250051434A1
(en)
|
2023-08-11 |
2025-02-13 |
Merck Sharp & Dohme Llc |
Monovalent interleukin 12 (il-12) heterodimeric fc proteins
|
|
WO2025051767A1
(en)
|
2023-09-04 |
2025-03-13 |
Sanofi |
Polypeptides for use in the treatment of glypican-3-expressing tumours
|
|
AR133903A1
(es)
|
2023-09-22 |
2025-11-12 |
Ablynx Nv |
Agentes de unión de albúmina bi- y multivalentes
|
|
TW202530265A
(zh)
|
2023-10-13 |
2025-08-01 |
美商奧迪希治療公司 |
抗cdh17抗原結合蛋白及其用途
|
|
WO2025090840A1
(en)
*
|
2023-10-27 |
2025-05-01 |
Rutgers, The State University Of New Jersey |
Antigen binding molecules targeting tnf-alpha
|
|
WO2025093683A1
(en)
|
2023-11-03 |
2025-05-08 |
Neuvasq Biotechnologies Sa |
Wnt7 signaling agonists
|
|
WO2025099632A1
(en)
|
2023-11-08 |
2025-05-15 |
Sanofi |
Cd25 based lysosomal degrader and uses thereof
|
|
WO2025109176A1
(en)
|
2023-11-22 |
2025-05-30 |
Exevir Bio Bv |
Optimized sarbecovirus spike s2 subunit binders and compositions comprising the same
|
|
WO2025114529A1
(en)
|
2023-12-01 |
2025-06-05 |
Ablynx Nv |
Multispecific antibodies recognising human serum albumin, tcr and a tumor antigen recognising moiety
|
|
WO2025125577A1
(en)
|
2023-12-14 |
2025-06-19 |
Vib Vzw |
Antibodies against influenza b virus
|
|
US20250236673A1
(en)
|
2023-12-22 |
2025-07-24 |
Ablynx N.V. |
Protein-based carriers for site-specific amine conjugation
|
|
WO2025133253A2
(en)
|
2023-12-22 |
2025-06-26 |
Ablynx Nv |
Protein-based conjugation carriers for intranuclear delivery
|
|
US12134635B1
(en)
|
2023-12-29 |
2024-11-05 |
Sonnet BioTherapeutics, Inc. |
Interleukin 18 (IL-18) variants and fusion proteins comprising same
|
|
WO2025147862A1
(zh)
*
|
2024-01-09 |
2025-07-17 |
上海洛启生物医药技术有限公司 |
血清白蛋白结合分子及其应用
|
|
WO2025154058A1
(en)
|
2024-01-21 |
2025-07-24 |
Ibi-Ag Innovative Bio Insecticides Ltd. |
Anti-insect hsp70 nanobodies and uses thereof
|
|
WO2025154056A1
(en)
|
2024-01-21 |
2025-07-24 |
Ibi-Ag Innovative Bio Insecticides Ltd. |
Anti-insect cda nanobodies and uses thereof
|
|
WO2025160546A1
(en)
|
2024-01-26 |
2025-07-31 |
The Johns Hopkins University |
Dendrimer conjugate compositions for intracellular delivery of antibodies and antibody fragments
|
|
WO2025181155A1
(en)
|
2024-02-26 |
2025-09-04 |
Vib Vzw |
Human beta-glucocerebrosidase binders and uses thereof
|
|
GB202403780D0
(en)
|
2024-03-15 |
2024-05-01 |
Avacta Life Sciences Ltd |
Polypeptides and methods for detecting and quantifying small molecules
|
|
WO2025196308A1
(en)
|
2024-03-22 |
2025-09-25 |
Vib Vzw |
Means and methods for displaying fc-containing proteins on cells and selection thereof
|
|
WO2025217240A1
(en)
|
2024-04-10 |
2025-10-16 |
Odyssey Therapeutics, Inc. |
Anti-tnfr2 antigen-binding proteins and uses thereof
|
|
US12459994B2
(en)
|
2024-04-12 |
2025-11-04 |
Paragon Therapeutics, Inc. |
Albumin binding proteins and methods of use
|
|
WO2025219231A1
(en)
|
2024-04-15 |
2025-10-23 |
Vib Vzw |
Computer-implemented means and methods for the de novo design of antibodies targeting a specific epitope
|